• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (199)   Subscriber (50361)
For: Ida H, Huang M, Hida A, Origuchi T, Kawakami A, Migita K, Tsujihata M, Mimori T, Eguchi K. Characterization of anticytoplasmic antibodies in patients with systemic autoimmune diseases. Mod Rheumatol 2003;13:333-8. [PMID: 24387255 DOI: 10.3109/s10165-003-0248-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Number Cited by Other Article(s)
1
Matsushita M, Matsudaira R, Ikeda K, Nawata M, Tamura N, Takasaki Y. Anti-proteasome activator 28α is a novel anti-cytoplasmic antibody in patients with systemic lupus erythematosus and Sjögren’s syndrome. Mod Rheumatol 2014. [DOI: 10.3109/s10165-009-0215-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
2
Matsushita M, Matsudaira R, Ikeda K, Nawata M, Tamura N, Takasaki Y. Anti-proteasome activator 28alpha is a novel anti-cytoplasmic antibody in patients with systemic lupus erythematosus and Sjögren's syndrome. Mod Rheumatol 2009;19:622-8. [PMID: 19688289 DOI: 10.1007/s10165-009-0215-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2009] [Accepted: 07/14/2009] [Indexed: 11/26/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA